- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
14
Mid-Large Cap Stocks
14 companies
Roche Holding
Market Cap: CHF 289.6b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 362.50
7D
4.3%
1Y
39.2%
Novartis
Market Cap: CHF 217.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 114.28
7D
2.3%
1Y
18.3%
Tecan Group
Market Cap: CHF 2.6b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 215.00
7D
9.1%
1Y
36.6%
Cosmo
Market Cap: CHF 899.1m
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
CMHC
CHF 52.30
7D
-2.6%
1Y
-21.7%
Sandoz Group
Market Cap: CHF 28.4b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 65.72
7D
-3.0%
1Y
37.2%
SKAN Group
Market Cap: CHF 1.4b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 63.00
7D
-0.9%
1Y
8.2%
Bachem Holding
Market Cap: CHF 5.8b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 76.95
7D
-0.6%
1Y
20.1%
Galderma Group
Market Cap: CHF 35.9b
Operates as a dermatology company worldwide.
GALD
CHF 154.05
7D
-0.9%
1Y
6.1%
Lonza Group
Market Cap: CHF 37.6b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 538.40
7D
0.07%
1Y
-1.4%
Dottikon ES Holding
Market Cap: CHF 3.6b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 260.00
7D
-2.8%
1Y
-12.3%
Basilea Pharmaceutica
Market Cap: CHF 825.8m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 66.50
7D
2.6%
1Y
44.4%
Siegfried Holding
Market Cap: CHF 3.2b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 72.70
7D
2.3%
1Y
-16.0%
Idorsia
Market Cap: CHF 1.3b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 4.95
7D
-3.2%
1Y
21.0%
PolyPeptide Group
Market Cap: CHF 1.5b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 44.10
7D
0.2%
1Y
70.3%